Research Analysts’ Updated EPS Estimates for August, 22nd (ALG, ATRA, AUDC, AVAL, AVHI, BAYK, BKH, BLPH, BLRX, BZLFY)

Research Analysts’ updated eps estimates for Tuesday, August 22nd:

Alamo Group (NYSE:ALG) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $100.00 target price on the stock. According to Zacks, “Alamo Group Inc. is a leading manufacturer of high quality equipment for right-of-way maintenance and agriculture. Their products include tractor-mounted mowing and other vegetation maintenance equipment, street sweepers, agricultural implements and related after market parts and services. They emphasize high quality, cost efficient products for their customers and strive to develop and market innovative products while constantly monitoring and containing their manufacturing and overhead costs. “

Atara Biotherapeutics (NASDAQ:ATRA) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. The company’s lead programs are focused on myostatin and activin, members of the TGF-beta family of proteins that have demonstrated the potential to have therapeutic benefit in a number of clinical indications. Its lead product candidate is PINTA 745, which is in a Phase II clinical trial for the treatment of protein-energy wasting in end-stage renal disease patients. Atara Biotherapeutics, Inc. is headquartered in Brisbane, California. “

AudioCodes (NASDAQ:AUDC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “AUDIOCODES LTD designs, develops and markets enabling technologies and communication components for the transmission of voice, fax and modem over packet networks. Newly developed Voice over IP gateways as well as DSL and ATM access devices, enable packet networks to carry voice and data more efficiently and at lower cost than traditional telephone networks. They are a provider of voice over packet communication components that empower the development of equipment for these emerging markets. “

Grupo Aval Acciones y Valores (NYSE:AVAL) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Grupo Aval Acciones y Valores S.A. is a financial services group. It provides a comprehensive range of financial services and products ranging from traditional banking services, such as making loans and taking deposits, to pension and severance fund management. The company also provides general purpose loans, foreign exchange services, documentation services, guarantees, auto financing, payroll loans, and credit cards, as well as various deposit and basic treasury products. It provides fiduciary services; merchandise storage and deposit, customs agency, cargo management, and merchandise distribution; brokerage services, fund management, portfolio management, securities management, and capital markets consulting services; and investment banking, treasury, and private banking services. Grupo Aval Acciones Y Valores S.A. is based in Bogotá, Colombia. “

A V Homes (NASDAQ:AVHI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “AV Homes, Inc. is engaged in homebuilding, land development and other real estate operations in Florida and Arizona. The company also builds homes in central Florida and Phoenix under its Joseph Carl Homes brand. It owns and operates active adult communities, including Solivita near Orlando and CantaMia near Phoenix. AV Homes, Inc., formerly known as Avatar Holdings Inc., is based in Poinciana, Florida. “

Bay Banks of Virginia (NASDAQ:BAYK) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $10.00 target price on the stock. According to Zacks, “Bay Banks of Virginia, Inc. is a bank holding company headquartered in Kilmarnock, Virginia. The Company conducts substantially all of its operations through its subsidiaries, Bank of Lancaster (the Bank) and Bay Trust Company (the Trust Company). Bank of Lancaster provides individual and commercial customers with a full range of services, including commercial and consumer deposit accounts and loans, credit cards, automated teller machines and other traditional banking services. In addition, the Bank offers investment services, including financial planning, securities brokerage, and insurance products through Investment Advantage. Bay Trust provides management services for personal and corporate trusts, including estate planning, estate settlement and trust administration. Bay Trust also offers financial planning, investment services, management of IRAs and other investment accounts. “

Black Hills Corporation (NYSE:BKH) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Black Hills Corporation is an energy company that generates wholesale electricity and produces natural gas, crude oil and coal. They serve natural gas and electric utility customers in Arkansas, Colorado, Iowa, Kansas, Montana, Nebraska, South Dakota and Wyoming. “

Bellerophon Therapeutics (NASDAQ:BLPH) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bellerophon Therapeutics LLC is a biotherapeutics company. It is focused on developing products for the treatment of cardiopulmonary and cardiac diseases. The company’s product pipeline consists of INOpulse and BCM which are in different clinical stage. Bellerophon Therapeutics LLC is based in Hampton, New Jersey. “

BioLineRx (NASDAQ:BLRX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company’s portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases. “

Bunzl plc (NASDAQ:BZLFY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bunzl Plc operates in two business areas; Outsourcing Services and Filtrona. As an international componay Bunzl has developed sound partnerships with both suppliers and customers by providing outsourcing solutions and customer service oriented distribution and light manufacture, primarily of plastic and paper based products. “

Cadence Bancorp (NYSE:CADE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Cadence BanCorporation is a regional bank holding company. It provides corporations, middle-market companies, small businesses and consumers banking and financial solutions. The company’s services and products include commercial and business banking, treasury management, specialized lending, commercial real estate, foreign exchange, wealth management, investment and trust services, financial planning, retirement plan management, business and personal insurance, consumer banking, consumer loans, mortgages, home equity lines and loans and credit cards. Cadence BanCorporation is headquartered in Houston, Texas. “

Green Swan Capital Corp. (TSE:CBLT) had its speculative buy rating reaffirmed by analysts at Canaccord Genuity. Canaccord Genuity currently has a C$10.00 target price on the stock.

Clinigen Group Plc (NASDAQ:CLIGF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $14.00 price target on the stock. According to Zacks, “Clinigen Group plc is a pharmaceutical and services company. Its business focuses in areas of global medicine supply; clinical trial, unlicensed and licensed medicines. Clinigen Group plc is headquartered in Burton-on-Trent, the United Kingdom. “

America’s Car-Mart (NASDAQ:CRMT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “America’s Car-Mart operates automotive dealerships and is one of the largest automotive retailers in the United States focused exclusively on the Buy Here/Pay Here segment of the used car market. The Company operates its dealerships primarily in small cities and rural locations throughout the South-Central United States, selling quality used vehicles and providing financing for substantially all of its customers. “

Carbo Ceramics (NYSE:CRR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “CARBO Ceramics Inc. is the world’s largest producer and supplier of ceramic proppants for use in the hydraulic fracturing of natural gas and oil wells. Demand for ceramic proppants depends primarily upon the demand for natural gas and oil and on the number of natural gas and oil wells drilled, completed or recompleted worldwide. More specifically, the demand for ceramic proppants is dependent on the number of oil and gas wells that are hydraulically fractured to stimulate production. “

Countrywide (NASDAQ:CYWDF) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Countrywide plc provides property services which includes estate agency and lettings network. The company’s business unit consists of Retail, London, B2B and Financial Services. Countrywide plc is headquartered in Milton Keynes, the United Kingdom. “

Danone (OTCMKTS:DANOY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Danone SA is engaged in food processing activities primarily in France and internationally. The Company operates in four business lines: Fresh Dairy Products, Waters, Baby Nutrition, and Medical Nutrition. The Fresh Dairy Products division produces and markets yogurts, fermented fresh dairy products, and other specialized fresh dairy products .The Waters division produces and distributes packaged natural, flavored, and vitamin-enriched water. The Baby Nutrition division provides food for infants and toddlers to complement breast-feeding. The Medical Nutrition division offers products to treat disease-related to malnutrition. Danone SA, formerly known as Groupe Danone, is based in Paris, France. “

Loop Capital started coverage on shares of Hewlett Packard Enterprise (NYSE:HPE). Loop Capital issued a hold rating on the stock.

Loop Capital assumed coverage on shares of HP (NYSE:HPQ). They issued a buy rating on the stock.

CIBC began coverage on shares of Redfin Corp (NASDAQ:RDFN). The firm issued an outperform rating and a $31.00 target price on the stock.

Synaptics (NASDAQ:SYNA) had its underperform rating reiterated by analysts at CIBC. The firm currently has a $35.00 price target on the stock, down from their previous price target of $45.00.